Convalescent Plasma or Hyperimmune Immunoglobulin for People with COVID-19 A Living Systematic Review

Piechotta, V., Iannizzi, C., Li Chai, K., et al. (2021). Convalescent Plasma or Hyperimmune Immunoglobulin for People with COVID-19: A Living Systematic Review. Cochrane Database of Systematic Reviews. 2021(5).
This living systematic review assesses the safety and effectiveness of convalescent plasma or hyperimmune immunoglobulin transfusions for the treatment of COVID-19. The authors conclude that convalescent plasma is not a beneficial treatment among patients with moderate to severe COVID-19.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.